The following are news releases and statements issued by Biosimilars Canada. News stories about biosimilars that may be of interest to readers are available here.
The establishment of the new CGPA Biosimilars Board signifies the focus our industry is placing on ensuring that Canada is a viable market for the production and sale of biosimilar treatments.